This is a preview of subscription content, log in via an institution to check access.
Reference
Chen P, et al. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report. World Journal of Clinical Cases 8: 2876-2884, No. 13, Jul 2020. Available from: URL: http://doi.org/10.12998/wjcc.v8.i13.2876
Rights and permissions
About this article
Cite this article
Antineoplastics/mesna. Reactions Weekly 1818, 44 (2020). https://doi.org/10.1007/s40278-020-82324-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-82324-7